Clinical Trial

Teclistamab in Previously Treated AL Amyloidosis

Name: Teclistamab in Previously Treated AL Amyloidosis — clinical trial record (NCT06935162)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase II study in patients with previously treated immunoglobulin light-chain (AL) Amyloidosis to evaluate the efficacy and safety of teclistamab

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-11.

Status change: Not Yet Recruiting → Recruiting 2025-05-21

Trial Details

NCT Number	NCT06935162
Lead Sponsor	Peking Union Medical College Hospital
Conditions	AL Amyloidosis
Enrollment	30 participants
Start Date	2025-05-21
Primary Completion	2026-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-05-25